News & Press: Advocacy News

CCTS Newsletter I July 6, 2018

Friday, July 6, 2018   (0 Comments)
Posted by: Andrea Van Hook
Share |

CCTS Newsletter

 Dale Dirks and Dane Christiansen

July 6, 2018

 The Senate continued its work on Fiscal Year (FY) 2019 appropriations and kept a promise to have all twelve spending bills marked up by the July 4th recess. The last two bills that received consideration and bipartisan approval by the Senate Appropriations Committee were the annual Department of Defense spending measure and the FY 2019 Labor-Health and Human Services-Education (L-HHS) Appropriations Bill. The House of Representatives had previously released a draft of its FY 2019 L-HHS bill, but that measure has yet to be considered. The appropriations bill are not expected to move before the August recess and subsequent campaign season, thus delaying any final action on FY 2019 appropriations until the lame duck session at the end of the year.

The FY 2019 Senate L-HHS Appropriations Bill and committee report calls for:   

  • $39.1 billion for NIH, an increase of $2 billion above FY 2018 and $750 million more than the House allocation.
  • $2.87 billion for the National Institute of General Medical Sciences (NIGMS), an increase of 88.89 million over FY 2018 and $55.62 million more than the House allocation.
  • $361.76 million for the Institutional Development Awards (IDeA) Program, an increase of $11.19 million over FY 2018 and $3.02 million less than the House allocation (please see below).
  • $314.85 million for the National Institute on Minority Health and Health Disparities (NIMHD), an increase of $9.74 million over FY 2018 and $6.12 million more than the House allocation.
  • $806.79 million for the National Center for Advancing Translational Sciences (NCATS), an increase of $44.3 million above FY 2018 and $35.43 million more than the House allocation.
  • At least $560 million for the Clinical and Translational Science Awards program (please see below), an increase of at least $17.23 million over both FY 2018 and the House allocation.
  • Up to $80 million for the Cures Acceleration Network (please see below), a potential increase of $55 million over FY 2018 and $50 million more than the House allocation.
  • $1.91 billion for the Office of the Director, an increase of $107.92 million above FY 2018 and $8.38 million more than the House allocation, including $606.86 million for the Common Fund.
  • $334 million for AHRQ, level funded with both FY 2018 and the House allocation.

Committee Recommendations

Clinical and Translational Science Awards (CTSA) Programs - The Committee encourages the NCATS to fund, through the existing CTSA program hubs, expanded efforts to improve translational research that address health disparities and the significant burden of conditions that disproportionately affect minority and special populations. Accelerating translational research by making it more efficient and effective will reduce the burden of disease among vulnerable populations. The Committee supports the goals of the NCATS program and believes the principles that serves as the foundation of NCATS; public-private partnerships, community outreach, faster access to clinical trials, have tremendous potential for addressing the long-standing diseases associated with health disparities. The Committee encourages NCATS to fund institutions with a history of serving health disparity populations. 

Research Training and Career Development - The Committee notes the important role that AHRQ plays in supporting research training and career development activities, such as "K" Awards and Mentored Clinical- Scientist Development Awards. Considering the current challenges facing physician-scientists and the young investigator pipeline, AHRQ is encouraged to continue to prioritize these activities.